Explore Novo Nordisk's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.
| Metric | 2025/12/31 | 2024 | 2023 | 2022 and older |
|---|---|---|---|---|
Total Board Members | 9a | N/A | N/A | |
Executive Board Members | 0a | N/A | N/A | |
Non-Executive Board Members | 9a | N/A | N/A | |
Independent Board Members | 2a | N/A | N/A | |
Non-Independent Board Members | 7a | N/A | N/A | |
Female Board Members | 4a | N/A | N/A | |
Male Board Members | 5a | N/A | N/A | |
Non-Binary Board Members | 0a | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.